United States Biotechnology & Medical Research

Cardio Diagnostics Holdings Inc (CDIO)

Track

The most recent insider trading activity at Cardio Diagnostics Holdings Inc. occurred on September 6, 2024. On this date, Chief Medical Officer Robert Philibert and Chief Technology Officer/CEO Meeshanthini Dogan executed multiple buy transactions, acquiring a significant number of shares. No insider trading activity has been reported within the last three months.
Ticker: CDIO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cardio Diagnostics Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Philibert Robert Chief Medical Officer Executive Director
Transaction date
Purchase
Price
321.16
Quantity 98,054 -23.8%
Value US$4,684,344
3.0
Philibert Robert Chief Medical Officer Executive Director
Transaction date
Purchase
Price
448.52
Quantity 87,694 +42.5%
Value US$2,515,952
3.1
Dogan Meeshanthini Chief Executive Officer Executive Director
Transaction date
Purchase
Price
433.45
Quantity 74,548 -36.6%
Value US$2,512,328
3.1
Dogan Meeshanthini Chief Technology Officer Officer
Transaction date
Purchase
Price
0.29
Quantity 68,965 +53.7%
Value US$20,000
2.7
Dogan Timur Chief Technology Officer Officer
Transaction date
Purchase
Price
0.55
Quantity 16,481 +14.7%
Value US$8,982
3.1
Dogan Meeshanthini Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.55
Quantity 16,481 +14.7%
Value US$8,982
3.0
Philibert Robert Chief Medical Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.57
Quantity 100 +0.0%
Value US$57
3.0
Philibert Robert Chief Medical Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 17,900 +1.1%
Value US$10,738
2.7
Dogan Timur Chief Technology Officer Officer
Transaction date
Purchase
Price
0.56
Quantity 1,770 +1.6%
Value US$982
3.1
Dogan Meeshanthini Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.56
Quantity 1,770 +1.6%
Value US$982
3.0
Philibert Robert Chief Medical Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 16,000 +1.0%
Value US$9,600
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-10 2024-09-06 B Purchase
3.0
Philibert Robert

Chief Medical Officer

Executive Director
98,054 -23.8%
321.16
US$4,684,344 		98,054 -23.8% 321.16 US$4,684,344
2024-09-10 2024-09-06 B Purchase
3.0
Philibert Robert

Chief Medical Officer

Executive Director
87,694 +42.5%
448.52
US$2,515,952 		87,694 +42.5% 448.52 US$2,515,952
2024-09-09 2024-09-06 B Purchase
3.1
Dogan Meeshanthini

Chief Executive Officer

Executive Director
74,548 -36.6%
433.45
US$2,512,328 		74,548 -36.6% 433.45 US$2,512,328
2024-09-09 2024-09-06 B Purchase
3.1
Dogan Meeshanthini

Chief Technology Officer

Officer
68,965 +53.7%
0.29
US$20,000 		68,965 +53.7% 0.29 US$20,000
2023-09-08 2023-08-31 B Purchase
2.7
Dogan Timur

Chief Technology Officer

Officer
16,481 +14.7%
0.55
US$8,982 		16,481 +14.7% 0.55 US$8,982
2023-09-08 2023-08-31 B Purchase
3.1
Dogan Meeshanthini

Chief Executive Officer

Executive Director Large shareholder
16,481 +14.7%
0.55
US$8,982 		16,481 +14.7% 0.55 US$8,982
2023-09-05 2023-08-28 B Purchase
3.0
Philibert Robert

Chief Medical Officer

Executive Director Large shareholder
100 +0.0%
0.57
US$57 		100 +0.0% 0.57 US$57
2023-09-05 2023-08-28 B Purchase
3.0
Philibert Robert

Chief Medical Officer

Executive Director Large shareholder
17,900 +1.1%
0.60
US$10,738 		17,900 +1.1% 0.60 US$10,738
2023-09-08 2023-08-25 B Purchase
2.7
Dogan Timur

Chief Technology Officer

Officer
1,770 +1.6%
0.56
US$982 		1,770 +1.6% 0.56 US$982
2023-09-08 2023-08-25 B Purchase
3.1
Dogan Meeshanthini

Chief Executive Officer

Executive Director Large shareholder
1,770 +1.6%
0.56
US$982 		1,770 +1.6% 0.56 US$982
2023-09-05 2023-08-24 B Purchase
3.0
Philibert Robert

Chief Medical Officer

Executive Director Large shareholder
16,000 +1.0%
0.60
US$9,600 		16,000 +1.0% 0.60 US$9,600
Explore more

More insider trading research around Cardio Diagnostics Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America